Adaptive Biotechnologies Corporation
ADPT
$17.43
$0.653.87%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.13% | -23.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.13% | -23.72% | |||
| Cost of Revenue | 5.86% | -4.40% | |||
| Gross Profit | -9.94% | -39.22% | |||
| SG&A Expenses | 7.48% | 6.30% | |||
| Depreciation & Amortization | -2.33% | 0.23% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.66% | 0.92% | |||
| Operating Income | -50.36% | -224.13% | |||
| Income Before Tax | -47.40% | -242.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -47.40% | -242.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -100.00% | |||
| Net Income | -47.53% | -242.25% | |||
| EBIT | -50.36% | -224.13% | |||
| EBITDA | -79.17% | -158.37% | |||
| EPS Basic | -45.21% | -241.69% | |||
| Normalized Basic EPS | -43.29% | -244.76% | |||
| EPS Diluted | -39.70% | -253.67% | |||
| Normalized Diluted EPS | -43.29% | -254.64% | |||
| Average Basic Shares Outstanding | 1.56% | 0.46% | |||
| Average Diluted Shares Outstanding | 1.56% | -6.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||